Skip to content

Author

Nazha Hamdani

We have 3 of 72 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Dapagliflozin in phenotypically stratified HFpEF without myocardial fibrosis: the STADIA-HFpEF randomized crossover trial.

AIMS Heart failure with preserved ejection fraction(HFpEF) is characterized by increased diastolic left ventricular(LV) stiffness resulting from variable contributions of myocardial extracellular matrix(ECM) remodeling and titin-based cardiomyocyte stiffness. Sodium-glucose cotransporter-2 inhibitors(SGLT2i) improved c...

Mariëlle Scheffer, Willemijn A. van Maarschalkerwaart, Chao-Hui Dong et al. · 0 citations
Review Open access Sep 2026

Sudden cardiac death in younger adults: a comparative analysis of coronary and non-coronary causes

Non-coronary and idiopathic etiologies represent a substantial proportion of SCD in younger adults and support standardized post-arrest evaluation, including multimodality imaging, inherited arrhythmia assessment, genetic testing, family screening, and longitudinal expert review.

Pia Thiesing, Andreas Smit, Hendrik Milting et al. · 0 citations
Review Open access Jul 2026

Extracellular Vesicles as Mediators of Pathophysiology and Disease Progression in Cardiovascular Diseases

It is confirmed that EVs carry disease-specific molecular cargo, particularly microRNAs, long non-coding RNAs, proteins, and other bioactive molecules, contributing to inflammation, oxidative stress, fibrosis, endothelial dysfunction, and cardiac remodeling, while also serving as promising diagnostic and prognostic bio...

M. Tangos, Luca Schneider, Oliver Jarkas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.